Ï㽶ÊÓƵ

McGill.CA / Cerveau en santé, vie en santé / Programmes de financement / Programme des subventions de neuro-commercialisation

Programme des subventions de neuro-commercialisation - Accelerate

Overview

The Healthy Brains, Healthy Lives (HBHL) initiative is a high profile, interdisciplinary initiative located at Ï㽶ÊÓƵ, and made possible with support from the (CFREF). HBHL’s strategic priorities are represented by its four Research Themes.

The Accelerate Grants are the second of two phases in the HBHL Neuro Commercialization Grants program. The objective of the Accelerate Grants is to support research aimed at improving the commercial potential of a neuroscience-related technology and to position it for commercial development.

Note: To be eligible for HBHL’s Accelerate Grants, applicants must have either a) successfully fulfilled all of the requirements of the Ignite phase and received approval from the HBHL Innovation Committee and NeuroSphere team to apply to the accelerate phase, or b) met with the NeuroSphere staff (including the Entrepreneur in Residence) to discuss the proposed project in depth to determine its suitability, in addition to receiving approval from the HBHL Innovation Committee to apply to the accelerate phase.

Funds available
  • Up to $200,000 for 18 months.
  • Funding is non-renewable.
  • Note: The Accelerate grant requires direct financial support from (a) commercial partner(s) or foundations. The total of the third-party contribution(s) must match HBHL’s contribution at a rate of at least 1:1. In-kind support is not considered a contribution to this requirement.

Timeline

 Open program: Applicants may apply at any time once they are able to meet program eligibility requirements.

Application process

Prerequisites:

  • A Report of Invention (ROI) must have been approved with Innovation and Partnerships Office at McGill (I+P).
  • To be eligible for HBHL’s Accelerate Grants, applicants must have either a) successfully fulfilled all of the requirements of the Ignite phase and received approval from the HBHL Innovation Committee and NeuroSphere team to apply to the accelerate phase, or b) met with the NeuroSphere staff (including the Entrepreneur in Residence) to discuss the proposed project in depth to determine its suitability, in addition to receiving approval from the HBHL Innovation Committee to apply to the accelerate phase.
  1. Applicants who have successfully completed the Ignite phase must have submitted a final report to HBHL. The Innovation Committee must have determined that the project is ready to move on to the Accelerate phase before applications will be deemed eligible for this funding.
  2. Applications will be reviewed internally for eligibility and relevance.
  3. Applications will be sent to a review committee, which will review the application for scientific excellence, potential for innovation and commercialization and long-term market potential.
  4. Out of the applications that are deemed fundable by reviewers, the Innovation Committee will make the final decision on funding.
  5. Successful applicants will be required to meet with NeuroSphere staff at the mid-point of the granting period to report on progress.

Successful applicants will be required to submit a final report to HBHL and meet with NeuroSphere at the end of the granting period to discuss their results.

Submission

.
Back to top